Cloud Defense Logo

Products

Solutions

Company

Book A Live Demo

CVE-2023-22868 : Security Advisory and Response

Learn about CVE-2023-22868, a cross-site scripting flaw in IBM Aspera Faspex 4.4.1 allowing potential credentials exposure. Moderate severity, mitigation steps included.

This CVE-2023-22868 pertains to a vulnerability found in IBM Aspera Faspex version 4.4.1 that allows for cross-site scripting, potentially leading to credentials disclosure within a trusted session.

Understanding CVE-2023-22868

This section will delve into the specifics of the CVE-2023-22868 vulnerability in IBM Aspera Faspex 4.4.1.

What is CVE-2023-22868?

CVE-2023-22868 involves a cross-site scripting vulnerability in IBM Aspera Faspex version 4.4.1. This flaw enables users to insert arbitrary JavaScript code into the Web UI, thereby altering the intended functionality and potentially exposing credentials within a trusted session.

The Impact of CVE-2023-22868

The impact of this vulnerability is moderate, with a base severity score of 5.4 (Medium) according to the CVSS v3.1 metrics. While the confidentiality and integrity impacts are low, the potential for credentials disclosure within a trusted session poses a significant risk.

Technical Details of CVE-2023-22868

In this section, we will explore the technical aspects of the CVE-2023-22868 vulnerability in IBM Aspera Faspex 4.4.1.

Vulnerability Description

The vulnerability stems from improper neutralization of input during web page generation, commonly known as 'Cross-site Scripting' (CWE-79). This allows attackers to inject malicious JavaScript code into the Web UI, compromising the system's security.

Affected Systems and Versions

IBM Aspera Faspex version 4.4.1 is the specific version impacted by this vulnerability in the IBM product line.

Exploitation Mechanism

Attackers can exploit this vulnerability by inserting crafted JavaScript code into input fields on the Web UI, tricking users into executing the code within their sessions, leading to potential credential exposure.

Mitigation and Prevention

To address the CVE-2023-22868 vulnerability and enhance security, it is crucial to implement the following mitigation strategies:

Immediate Steps to Take

        Update to a patched version of IBM Aspera Faspex that addresses the cross-site scripting vulnerability.
        Educate users on safe browsing practices to minimize the risk of executing malicious scripts.

Long-Term Security Practices

        Regularly monitor and audit web applications for security vulnerabilities, including cross-site scripting.
        Implement robust input validation and output encoding techniques to prevent script injection.

Patching and Updates

Stay informed about security advisories from IBM and promptly apply patches and updates to mitigate risks associated with known vulnerabilities. Regularly check for vendor advisories and security updates to protect your systems from potential exploits.

Popular CVEs

CVE Id

Published Date

Is your System Free of Underlying Vulnerabilities?
Find Out Now